How modifications to a specific receptor affect its signaling
Regulation of beta2-adrenergic receptor signaling by post-translational modifications
This study is looking at how certain changes to a protein in our body can affect how a key receptor works, which is important for treating conditions like asthma and heart issues, with the hope of creating better and safer medications for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-10678654 on NIH RePORTER |
What this research studies
This research investigates how post-translational modifications, specifically palmitoylation and glycosylation, influence the signaling of the beta2-adrenergic receptor, which plays a crucial role in various physiological processes. By examining these modifications, the research aims to understand how they affect the receptor's structure and its interactions with drugs. This could lead to better drug design and more effective treatments for conditions like asthma and cardiovascular diseases. Patients may benefit from insights that could improve medication efficacy and reduce side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from asthma or cardiovascular disorders who may benefit from improved drug therapies.
Not a fit: Patients with conditions unrelated to beta2-adrenergic receptor signaling may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted therapies for asthma and other related conditions.
How similar studies have performed: Previous research has shown promising results in understanding GPCR signaling and its implications for drug design, indicating that this approach has potential for success.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Lerch, Michael Taylor — Medical College of Wisconsin
- Study coordinator: Lerch, Michael Taylor
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.